Mithrl is a San Francisco-based AI infrastructure company for biopharma. Its Scientific Decision Engine turns raw sequencing and other omics data into auditable, biologically grounded insights used in drug-program decisions such as target identification, biomarker discovery and mechanism-of-action analysis. The platform is deployed inside partners environments with custom workflows built for each program, and the company reports customers reaching program decisions up to 32 times faster.
1
Round
1
Industry
5
Tags
Sep 15, 2026
Latest raise
Funding activity · 1 round
Sep 15, 2026
$20M
Series A
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
